JSAM
KMTS

J. Safra Asset Management’s Kestra Medical Technologies KMTS Stock Holding History

J. Safra Asset Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.25K Buy
213
+162
+318% +$3.82K ﹤0.01% 497
2025
Q4 		$1.35K Buy
+51
New +$1.31K ﹤0.01% 610

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

J. Safra Asset Management's KMTS Position: Q1 2026 in Review

J. Safra Asset Management increased its Kestra Medical Technologies (KMTS) stake by 318% in Q1 2026, buying an estimated $3.82K and bringing the position to 213 shares worth $4.25K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

J. Safra Asset Management first reported a position in KMTS in Q4 2025 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • J. Safra Asset Management held 213 shares of Kestra Medical Technologies worth $4.25K as of Q1 2026.
  • J. Safra Asset Management bought 162 Kestra Medical Technologies shares in Q1 2026, an estimated $3.82K.
  • Kestra Medical Technologies made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #497 holding.
  • J. Safra Asset Management first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.